- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05863416
Dexmedetomidine in Non-intubated VATS
May 16, 2023 updated by: Wei-Cheng Tseng, Tri-Service General Hospital
Adjunctive Dexmedetomidine Infusion in Non-intubated Video-assisted Thoracoscopic Surgery
This prospective study aims to evaluate the effectiveness of intraoperative DEX for postoperative analgesia and recovery after non-intubated VATS.
In addition, the investigators observe the impact of DEX on anesthetic requirements, hemodynamic parameters, and adverse events during non-intubated VATS.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The non-intubated thoracoscopic approach has been adapted for use with major lung resections.
The non-intubated VATS tries to minimize the adverse effects of tracheal intubation and general anesthesia, such as intubation-related airway trauma, ventilation-induced lung injury, residual neuromuscular blockade, and postoperative nausea and vomiting.
An adequate analgesia allows VATS to be performed in sedated patients and the potential adverse effects related to general anesthesia and selective ventilation can be avoided.
Dexmedetomidine (DEX), a highly selective alpha-2 receptor agonist, is increasingly used in anesthesia with sedative, hypnotic, anxiolytic, sympatholytic, and analgesic effects.
It can also attenuate perioperative stress and inflammation and preserve the immunity of surgical patients, which may contribute to reduced postoperative complications and improved clinical outcomes.
This study aims to evaluate the effectiveness of intraoperative DEX for postoperative analgesia and recovery after non-intubated VATS.
In addition, the investigators observe the impact of DEX on anesthetic requirements, hemodynamic parameters, and adverse events during non-intubated VATS.
Study Type
Interventional
Enrollment (Anticipated)
144
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wei-Cheng Tseng, MD
- Phone Number: 13815 886-2-8792-3311
- Email: ndmc_wechern@yahoo.com.tw
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) score of I-III patients receiving video-assisted thoracoscopic surgery
Exclusion Criteria:
- Age < 18 or > 80 years
- ASA classifications > III
- Pregnancy
- Known allergies to any drugs used in the study
- Emergency surgery
- Patient refusal
- Chronic pain history
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group Saline
Propofol-based total intravenous anesthesia with saline infusion
|
Intraoperative dexmedetomidine infusion
|
Experimental: Group Dexmedetomidine
Propofol-based total intravenous anesthesia with dexmedetomidine infusion
|
Intraoperative dexmedetomidine infusion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cough
Time Frame: Intraoperative period
|
The incidence of cough reflex during surgery and severity Cough severity: 1=none, 2=slight, 3=moderate, 4=severe
|
Intraoperative period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intraoperative fentanyl consumption
Time Frame: Intraoperative period
|
Fentanyl bolus for cough reflex and limb movement
|
Intraoperative period
|
Total fentanyl consumption
Time Frame: Intraoperative period
|
Total fentanyl requirement during surgery
|
Intraoperative period
|
Total propofol consumption
Time Frame: Intraoperative period
|
Total propofol requirement during surgery
|
Intraoperative period
|
Intraoperative adverse events
Time Frame: Intraoperative period
|
The incidence of hypotension, bradycardia and hypoxia
|
Intraoperative period
|
Postoperative numeric rating scale
Time Frame: Postoperative 48 hours
|
Numeric rating scale within postoperative 48 hours NRS scores is labeled from zero to ten, with zero being an example of someone with no pain and ten being the worst pain possible.
|
Postoperative 48 hours
|
Postoperative opioid requirement
Time Frame: Postoperative 48 hours
|
Postoperative opioid requirement within postoperative 48 hours
|
Postoperative 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Feray S, Lubach J, Joshi GP, Bonnet F, Van de Velde M; PROSPECT Working Group *of the European Society of Regional Anaesthesia and Pain Therapy. PROSPECT guidelines for video-assisted thoracoscopic surgery: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2022 Mar;77(3):311-325. doi: 10.1111/anae.15609. Epub 2021 Nov 5.
- Selim J, Jarlier X, Clavier T, Boujibar F, Dusseaux MM, Thill J, Borderelle C, Ple V, Baste JM, Besnier E, Djerada Z, Compere V. Impact of Opioid-free Anesthesia After Video-assisted Thoracic Surgery: A Propensity Score Study. Ann Thorac Surg. 2022 Jul;114(1):218-224. doi: 10.1016/j.athoracsur.2021.09.014. Epub 2021 Oct 15.
- Wang YL, Kong XQ, Ji FH. Effect of dexmedetomidine on intraoperative Surgical Pleth Index in patients undergoing video-assisted thoracoscopic lung lobectomy. J Cardiothorac Surg. 2020 Oct 2;15(1):296. doi: 10.1186/s13019-020-01346-1.
- Wang XR, Jia XY, Jiang YY, Li ZP, Zhou QH. Opioid-free anesthesia for postoperative recovery after video-assisted thoracic surgery: A prospective, randomized controlled trial. Front Surg. 2023 Jan 6;9:1035972. doi: 10.3389/fsurg.2022.1035972. eCollection 2022.
- Lee SH, Lee CY, Lee JG, Kim N, Lee HM, Oh YJ. Intraoperative Dexmedetomidine Improves the Quality of Recovery and Postoperative Pulmonary Function in Patients Undergoing Video-assisted Thoracoscopic Surgery: A CONSORT-Prospective, Randomized, Controlled Trial. Medicine (Baltimore). 2016 Feb;95(7):e2854. doi: 10.1097/MD.0000000000002854.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2023
Primary Completion (Anticipated)
April 1, 2025
Study Completion (Anticipated)
April 1, 2025
Study Registration Dates
First Submitted
May 3, 2023
First Submitted That Met QC Criteria
May 16, 2023
First Posted (Actual)
May 18, 2023
Study Record Updates
Last Update Posted (Actual)
May 18, 2023
Last Update Submitted That Met QC Criteria
May 16, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Dexmedetomidine
Other Study ID Numbers
- B202305049_V2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to share
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
Mansoura UniversityNot yet recruiting
-
Southeast University, ChinaRecruiting
-
Medical University of South CarolinaRecruiting
-
Southeast University, ChinaRecruiting
-
Huazhong University of Science and TechnologyRecruiting
-
Mansoura UniversityCompleted
-
University of FloridaMdoloris Medical SystemsCompletedAnalgesiaUnited States
-
Mansoura UniversityCompleted
-
Cessatech A/SCompleted
-
Kalyra Pharmaceuticals, Inc.United States Department of Defense; PRA Health SciencesTerminated
Clinical Trials on Dexmedetomidine infusion
-
Anqing Municipal HospitalCompletedDexmedetomidine, Esketamine, Postoperative Pain and Recovery QualityChina
-
Joseph CraveroCompletedEpilepsy | Cerebral Palsy | Developmental DelayUnited States
-
Anqing Municipal HospitalCompletedDexmedetomidine | Nausea and Vomiting, Postoperative | LidocaineChina
-
Yonsei UniversityCompletedSleep Apnea SyndromeKorea, Republic of
-
Assiut UniversityCompleted
-
Menoufia UniversityCompleted
-
Cairo UniversityUnknownEffect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG SurgerySublingual MicrocirculationEgypt
-
Anqing Municipal HospitalCompletedDexmedetomidine | Lidocaine | Quality of Recovery(QoR-40), Preoperative and PostoperativeChina
-
Yonsei UniversityCompleted
-
Peking University First HospitalBeijing HospitalNot yet recruitingSleep Quality | Dexmedetomidine | Old Age | Knee Replacement Surgery | Hip Replacement SurgeryChina